三阴性乳腺癌：一个不公平的竞争环境。 - Suppr

Quadruple-Negative Breast Cancer: An Uneven Playing Field.

作者信息

Saini Geetanjali, Bhattarai Shristi, Gogineni Keerthi, Aneja Ritu

机构信息

Department of Biology, Georgia State University, Atlanta, GA.

Department of Hematology and Medical Oncology, Emory University School of Medicine; Atlanta, GA.

出版信息

JCO Glob Oncol. 2020 Feb;6:233-237. doi: 10.1200/JGO.19.00366.

DOI:10.1200/JGO.19.00366

PMID:32073910

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7051792/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e056/7051792/5cf8e2a1fb4f/JGO.19.00366f1.jpg

相似文献

Quadruple-Negative Breast Cancer: An Uneven Playing Field.

JCO Glob Oncol. 2020 Feb;6:233-237. doi: 10.1200/JGO.19.00366.

How high a bar to change neoadjuvant therapy for triple-negative breast cancer?

J Comp Eff Res. 2015 Aug;4(4):293-6. doi: 10.2217/cer.15.29.

Where do the immune checkpoint inhibitors stand in the management of triple negative breast cancer?

Immunotherapy. 2018 Feb 1;10(4):247-250. doi: 10.2217/imt-2017-0171.

Novel therapies for triple-negative breast cancer.

Clin Adv Hematol Oncol. 2020 Dec;18(12):799-801.

MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2800-2809. doi: 10.1080/21691401.2019.1638791.

[Triple Negative Breast Cancer].

Klin Onkol. 2015;28(6):405-15.

Practical Approach to Triple-Negative Breast Cancer.

J Oncol Pract. 2017 May;13(5):293-300. doi: 10.1200/JOP.2017.022632.

Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer.

Surg Clin North Am. 2018 Aug;98(4):773-785. doi: 10.1016/j.suc.2018.04.004.

Triple-negative breast cancers - a panoply of cancer types.

Nat Rev Clin Oncol. 2018 Jun;15(6):347-348. doi: 10.1038/s41571-018-0001-7.

[Triple-negative breast cancer therapy via nectin-4 targeting].

Med Sci (Paris). 2017 Nov;33(11):936-939. doi: 10.1051/medsci/20173311007. Epub 2017 Dec 4.

引用本文的文献

Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer.

Int J Mol Sci. 2024 Dec 21;25(24):13679. doi: 10.3390/ijms252413679.

Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics.

Steroids. 2024 Oct;210:109486. doi: 10.1016/j.steroids.2024.109486. Epub 2024 Aug 5.

Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria.

Ecancermedicalscience. 2022 Oct 3;16:1452. doi: 10.3332/ecancer.2022.1452. eCollection 2022.

Interface between obesity with dysfunctional metabolism and inflammation, and the triple-negative breast cancer in African American women.

Explor Target Antitumor Ther. 2021;2(6):602-616. doi: 10.37349/etat.2021.00066. Epub 2021 Dec 31.

Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer.

Biomedicines. 2022 Feb 2;10(2):366. doi: 10.3390/biomedicines10020366.

Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors.

JCO Glob Oncol. 2021 Jul;7:1129-1140. doi: 10.1200/GO.21.00082.

Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials.

Breast Cancer Res Treat. 2021 Jun;187(3):605-611. doi: 10.1007/s10549-021-06264-x. Epub 2021 Jun 2.

Androgen Receptor and Expression in Tumor Tissue of Patients With Triple-negative Breast Cancer.

Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):147-156. doi: 10.21873/cgp.20249.

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies.

Cancers (Basel). 2020 Aug 24;12(9):2392. doi: 10.3390/cancers12092392.

本文引用的文献

Hereditary Susceptibility for Triple Negative Breast Cancer Associated With Western Sub-Saharan African Ancestry: Results From an International Surgical Breast Cancer Collaborative.

Ann Surg. 2019 Sep;270(3):484-492. doi: 10.1097/SLA.0000000000003459.

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.

Cancers (Basel). 2019 Jul 17;11(7):995. doi: 10.3390/cancers11070995.

Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:3-10. doi: 10.1200/EDBK_100021. Epub 2019 May 17.

Recent advances in triple negative breast cancer: the immunotherapy era.

BMC Med. 2019 May 9;17(1):90. doi: 10.1186/s12916-019-1326-5.

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.

Sci Rep. 2019 Feb 7;9(1):1538. doi: 10.1038/s41598-018-38364-y.

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment.

Cancer Discov. 2019 Feb;9(2):176-198. doi: 10.1158/2159-8290.CD-18-1177. Epub 2019 Jan 24.

Quadruple Negative Breast Cancers (QNBC) Demonstrate Subtype Consistency among Primary and Recurrent or Metastatic Breast Cancer.

Transl Oncol. 2019 Mar;12(3):493-501. doi: 10.1016/j.tranon.2018.11.008. Epub 2018 Dec 27.

Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants.

Cancers (Basel). 2018 Dec 14;10(12):514. doi: 10.3390/cancers10120514.

The Androgen Receptor in Breast Cancer.

Front Endocrinol (Lausanne). 2018 Aug 28;9:492. doi: 10.3389/fendo.2018.00492. eCollection 2018.

CDK4/6 inhibition in breast cancer: current practice and future directions.

Ther Adv Med Oncol. 2018 Jul 17;10:1758835918786451. doi: 10.1177/1758835918786451. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Quadruple-Negative Breast Cancer: An Uneven Playing Field.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献